• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Rexahn Pharmaceuticals, Inc. (RNN)

    -NYSE MKT
    0.36 Down 0.01(2.43%) 4:00PM EST
    Prev Close:0.37
    Open:0.37
    Bid:0.30 x 4000
    Ask:0.40 x 7700
    1y Target Est:2.83
    Beta:-1.08146
    Earnings Date:Mar 15 - Mar 21 (Est.)
    Day's Range:0.35 - 0.37
    52wk Range:0.26 - 0.85
    Volume:250,600
    Avg Vol (3m):473,192
    Market Cap:71.40M
    P/E (ttm):N/A
    EPS (ttm):-0.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RNN

    Comparison

    Symbol% ChgMkt Cap
    RNNDown 2.43%71.40M
    GSKDown 0.54%98.64B
    PFEUp 0.10%179.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.09
    Quarterly EPS Est (Dec-15) :-0.03
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer and other medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback